ArticleCureus2024
Cervical Granulocytic Sarcoma Without Acute Leukemia: A Case Report and Review of 42 Additional Cases.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Rare Cervical Manifestation of Acute Myeloid Leukemia: Granulocytic Sarcoma Simulating as a Gynecologic Tumor.Case reports in oncological medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Granulocytic sarcoma (GS), also known as extramedullary myeloid tumor, is a rare malignant neoplasm composed of immature myeloid cells. Although it is most commonly associated with acute myeloid leukemia (AML), a subset of GS cases can occur prior to the development of AML. GS can present in a variety of extramedullary locations, including bone, skin, lymph nodes, and the female reproductive system. We report the case of a 45-year-old Asian female patient who presented to our hospital in July 2015 with a three-month history of left-sided lumbago. A contrast-enhanced computed tomography (CT) scan of the abdomen and pelvis revealed a retroperitoneal mass and an enlarged uterine cervix with an accompanying 57×52 mm mass. A cervical biopsy confirmed the diagnosis of GS. Immunohistochemical (IHC) analysis of the biopsy showed that the neoplastic cells were positive for CD34, CD15, CD33, CD43, lysozyme, and myeloperoxidase. The patient was subsequently treated with an idarubicin and cytarabine-based regimen for four cycles. A follow-up CT scan of the abdomen and pelvis demonstrated a significant reduction in the size of the previous lesions. Unfortunately, the patient passed away in April 2016 due to a cerebral hemorrhage. In this report, we also review 42 additional cases to discuss the pathological characteristics, treatment strategies, and clinical outcomes of GS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.